Cargando…
PK‐PD modeling of individual lesion FDG‐PET response to predict overall survival in patients with sunitinib‐treated gastrointestinal stromal tumor
Pharmacometric models were developed to characterize the relationships between lesion‐level tumor metabolic activity, as assessed by the maximum standardized uptake value (SUV(max)) obtained on [(18)F]‐fluorodeoxyglucose (FDG) positron emission tomography (PET), tumor size, and overall survival (OS)...
Autores principales: | Schindler, E, Amantea, MA, Karlsson, MO, Friberg, LE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846778/ https://www.ncbi.nlm.nih.gov/pubmed/27299707 http://dx.doi.org/10.1002/psp4.12057 |
Ejemplares similares
-
PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GIST
por: Hansson, E K, et al.
Publicado: (2013) -
PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and
Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013) -
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients
por: Schindler, E, et al.
Publicado: (2017) -
PK/PD modeling based on NO-ET homeostasis for improving management of sunitinib-induced hypertension in rats
por: Liu, Hao-chen, et al.
Publicado: (2020) -
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
por: Mulet-Margalef, Nuria, et al.
Publicado: (2016)